The Association of Pharmaceutical Companies «Innovative Pharma» (InPharma) brings together major pharmaceutical companies that actively invest in research and development and are counted among the top 20 global pharmaceutical producers. Members of the association have research facilities all over the world and also work with Russian R&D centres to conduct clinical trials, cooperating with more than 250 R&D facilities across Russia. Members of the Association carry out research and development in the most important medical fields such as cardiology, endocrinology, psychiatry, neurology, oncology, urology, gastroenterology and diabetology. With a view towards developing partnership for innovative pharmaceutical R&D, members of the Association are entering into partnership agreements with the Russian development institutions the Skolkovo Innovation Centre and the Russian Venture Capital Company, as well as developing projects to modernise the biomedicine and biopharmaceutical sectors in Russia, and investing in the construction of manufacturing facilities and research laboratories.